When three patients die after taking a cutting-edge drug, most companies hit the brakes. Not Sarepta Therapeutics. The ...

Drugmaker Sarepta Therapeutics said late Friday it won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the ...

The company will pause several gene therapy development programs, for which it intends to seek partners and other strategic alternatives.

The company aims to focus on high-impact programmes to meet its 2027 financial obligations and support long-term viability.

Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...

Investing.com -- Sarepta Therapeutics (NASDAQ: SRPT) stock soared 36% in after-hours trading Wednesday after the biotech company announced a major strategic restructuring plan designed to ensure ...

Learn how Sacramento-area universities like UC Davis drive economic growth, STEM careers and agriculture, while facing unprecedented funding threats.

Microsoft will lay off nearly 4% of its workforce, the company said on Wednesday, in the latest job cuts as the tech giant looks to rein in costs amid hefty investments in artificial intelligence ...

So far in 2025, companies have announced 744,308 job cuts—the most at this point in the year since the pandemic.

Microsoft is cutting nearly 9,000 jobs in its biggest layoff since 2023, aligning with its focus on AI and streamlining operations.

Companies are removing entry-level jobs as AI takes over ...